redalpine has joined the £17 million Series A round for Hypervision Surgical, a King’s College London spinout developing real-time hyperspectral imaging technology for surgery. Led by Heal Capital, the round also includes healthcare specialists and strategic investors, reflecting strong confidence in the company’s ability to improve surgical decision-making and patient outcomes.
The funding will accelerate commercial rollout of Hypervision Surgical’s HYPERSNAP system and expand clinical adoption of its next-generation sensing technology. For redalpine, the investment underscores its commitment to backing high-impact medtech businesses emerging from deep scientific and clinical innovation.
Required for the website to work, for example security features and remembering your cookie choices. These cannot be switched off.
Help us understand how visitors use the website so we can improve it.
Used to show relevant ads and measure their effectiveness, and by embedded content such as videos and maps from other websites.